We previously demonstrated that the Groucho protein AES (amino-terminal enhancer of split) functions as a co-repressor of the AR (androgen receptor). It physically interacts with the N-terminal domain of AR and inhibits AR-driven transcription, but the molecular mechanism of its action remained unclear. In the present paper we report that the AES protein contains one inhibitory domain, and one positive and one negative regulatory domain. The negative regulatory domain inhibits AES dimerization and AES-mediated inhibition of AR-driven transcription through an interaction with the inhibitory domain. The positive regulatory domain blocked this interaction and relieved the inhibitory effect. In addition, we discovered mechanisms by which AES regulates AR transcriptional activity, which included disruption of the interaction between the AR Nterminal and C-terminal domains, and inhibition of AR-DNA interaction. Although AES broadly inhibited the activity of androgen-dependent luciferase reporters in a transient transfection assay, it selectively regulated the expression of endogenous androgen-dependent genes in prostate cancer cells.
INTRODUCTION
The AR (androgen receptor) is a ligand-activated DNA-binding transcriptional factor [1] [2] [3] [4] [5] [6] . Upon binding to androgen, AR interacts with the ARE (androgen-response element) in the promoter regions of its target genes and regulates their expression. AR is required for development and maintenance of the prostate gland and is closely linked with prostate tumorigenesis and prostate cancer progression [7] [8] [9] [10] . The transcriptional activity of AR is regulated by various cofactors (co-regulators) [1] [2] [3] [4] 11, 12] . The ability of AR to translocate to the nucleus and bind to the target gene promoter is essential for its biological function, and a number of negative co-repressors impinge upon this process to modulate AR activity [13] [14] [15] [16] . Some co-repressors inhibit AR-dependent transcription by recruiting histone deacetylases to AR target genes to trigger chromatin condensation and/or modifications [12, 17, 18] . Ligand binding to AR induces an interaction between the AR-N (AR N-terminal domain), which contains a Phe 23 -Xaa-Xaa-Leu-Phe 27 motif, and the hydrophobic surface of the AR-C (AR C-terminal domain), which mediates ligand binding. This interaction leads to enhanced receptor stability and activity [19, 20] . Studies have shown that corepressors such as human Rad9 and caspase-8 modulate AR-N-AR-C interactions to affect AR transactivation [21] [22] [23] [24] [25] [26] .
We have shown previously that AES (amino-terminal enhancer of split) functions as a co-repressor of AR [27] ; AES physically interacts with AR-N and inhibits AR-driven transcription, but the molecular mechanism of its action remained unclear. AES belongs to the Groucho protein family [28] , which can be divided into two distinct subgroups. The proteins in the first subgroup consist of a highly conserved glutamine-rich N-terminus, a Cterminal WD repeat domain (i.e. a domain containing repeated protein motifs of tryptophan and aspartic acid residues) and a variable central region. The N-terminal domain mediates homoand hetero-oligomerization of the Groucho proteins, which are essential for Groucho-mediated transcriptional repression [29] . In comparison, the WD repeat domain usually contains four to eight WD repeats and mediates protein-protein interactions with DNA-binding activators and repressors. The first subgroup includes the human TLE (transducin-like enhancer of split) proteins. The second subgroup, or the AES subgroup, contains the sequence corresponding to the N-terminal region of the first subgroup but lacks the entire WD repeat domain and most of the variable central region. Investigators have generated mice lacking AES; these mice exhibited a growth defect, as well as skeletal abnormalities [30, 31] . Transgenic mice overexpressing AES died in utero [32] . These studies indicated that AES plays a crucial role in the regulation of developmental processes in mice.
In an effort to further understand the mechanism by which AES represses AR-driven transcription, we examined the structure and functions of AES in AR-driven transcription. We found that the AES protein forms a homodimer, which is essential for AES-mediated transcriptional repression of AR-driven gene expression. Furthermore, we observed that the AES protein contains an inhibitory domain, and one positive and one negative regulatory domain. AES disrupted the AR-N-AR-C interaction and inhibited the AR-DNA interaction, two processes that are believed to be responsible for AES repression of AR-regulated genes. We also assessed the gene specificity of AES and found that it selectively regulated androgen-driven gene expression in prostate cancer cells.
EXPERIMENTAL

DNA constructs and reagents
The FLAG, HA (haemagglutinin) or Myc epitope was fused at the N-terminus or C-terminus of AES, or the AES truncations, which were subcloned into pcDNA3.1 (Invitrogen) or pET15b (Novagene) to generate wild-type and deletion AES expression plasmids (pcDNA-f:AES, pcDNA-f:AES deletions, pcDNA-AES-FHM, pET-f:AES or pET-f:AES deletions). The DNA sequence encoding the DNA-binding domain (amino acid residues 1-149) of the yeast Gal4 protein was fused with the DNA sequence encoding the human herpes virus VP16 (virus protein 16) activation domain (amino acid residues 363-490). The DNA fragment encoding the Gal4-VP16 fusion protein was subcloned into pcDNA3.1 and pET15b to generate pcDNA-Gal4-VP16 and pET-Gal4-VP16 respectively. R-1881 (methyltrienolone), an androgen analogue, was obtained from NEN Chemicals. A rabbit polyclonal anti-AES antibody was prepared as described previously [27] . The antibody was purified through an antigenaffinity column.
Luciferase assay
The luciferase reporter plasmid containing four tandem copies of the ARE from the PSA (prostate-specific antigen) gene upstream of the minimal adenovirus E4 promoter was generated as described previously [33] [34] [35] [36] [37] . Luciferase reporters containing the MMTV (mouse-mammary-tumour virus) promoter, a PSA enhancer (− 4354 to − 3858, relative to the transcription start site), the probasin gene (− 244 to +28), c-FLIP (cellular Fas-associated death domain-like interleukin 1β-converting enzyme-inhibitory protein; − 48 to +156), and IGFBP5 (insulin-like-growth-factorbinding protein 5; − 98 to +148) were generated as described previously [33] [34] [35] 37] . The pG5-luc reporter was purchased from Promega.
PC3 prostate cancer cells were obtained from the A.T.C.C. and maintained in RPMI 1640 medium plus 10 % (v/v) FBS (fetal bovine serum). Cells were plated on to 24-well plates (1.6 ×10 4 cells/well) and transfected 24 h later with 25 fmol of a luciferase reporter plasmid, 0.8 fmol of a pR-LUC internal control plasmid and the indicated amounts of expression plasmids. The total amount of DNA was adjusted to 75 fmol using pcDNA3.1. The transfection was conducted using Lipofectamine TM (Invitrogen) in serum-and Phenol-Red-free RPMI 1640 medium. After 6 h of transfection, the medium was exchanged for regular RPMI 1640 medium plus 10 % (v/v) FBS or Phenol Red-free RPMI 1640 medium plus 10 % (v/v) charcoal-stripped FBS and 10 nM R-1881. Cells were cultured for another 48 h and harvested for analysis in a dual-luciferase assay (Promega). Three independent experiments were performed for each transient transfection assay.
Protein-protein interaction assay
For the pull-down assay, FLAG-tagged proteins (1 μg each) expressed in bacteria, via the pET-f:AES and pET-f:AES deletion plasmids, were immobilized in 20 μl of M2 agarose beads (Sigma-Aldrich). The beads were incubated with 5 μl of rabbit reticulocyte lysate containing 35 S-labelled proteins produced by the TNT ® cell-free protein expression system (Promega) in a final volume of 200 μl containing 20 mM Hepes, pH 7.9, 0.2 mM EDTA, 20 % (v/v) glycerol, 2 mM dithiothreitol, 150 mM KCl and 0.1 % Nonidet P-40. The beads were washed with 1 ml of the incubation buffer five times, boiled in 20 μl of SDS gel sample buffer and analysed using SDS/PAGE (12 % gels) followed by autoradiography.
Mammalian two-hybrid analysis was performed using the CheckMate TM Mammalian Two-Hybrid System (Promega). PC3 cells were transfected with pG5-luc reporter, pACT-AR-N (amino acid residues 1-662), pBIND-AR-C (amino acid residues 663-917), pBIND-AR-N (amino acid residues 1-662), pBIND-AR (amino acid residues 1-197) and pcDNA-AES as indicated. The pRL-CMV plasmid was included in the transfection as an internal control. Transfected cells were incubated for 36-48 h in a medium containing 10 nM R-1881 and then harvested for the luciferase assay. The plasmids pACT-ID and pBIND-MyoD provided with the CheckMate TM system were used as positive controls.
Electrophoretic mobility-shift assay
The human AR protein was expressed in Sf9 cells and purified as described previously [38] . The human recombinant AES, AES-(1-129) and Gal4-VP16 proteins were expressed using the pET15d vector in Escherichia coli BL21 cells and purified using Ni 2+ -nitrilotriacetate-agarose. The wild-type (5 -ATTGCAGAACAGCAAGTGCTAGCTC-3 ) and mutant (5 -ATTGCAGAAtAGCAAaTGCTAGCTC-3 ; mutant nucleotides are indicated by lower-case letters) AREcontaining probes were derived from the PSA gene [38] . The 120-bp probe containing five Gal4 DNA-binding sites was prepared by digesting the pG5-luc construct with restriction enzymes, followed by agarose gel purification. Probes were labelled with [α-32 P]dCTP using a fill-in reaction with the Klenow enzyme. For the gel-shift assays, 20 μl of reaction mixture, containing 20 mM Hepes, pH 7.9, 70 mM KCl, 1 μg of poly(dI-dC) · (dI-dC), 1 mM dithiothreitol, 0.1 % Nonidet P40, 100 μg/ml BSA, 40 ng of recombinant AR or 1 ng of recombinant Gal4-VP16 and the indicated amounts of AES were used. The reaction mixture was incubated for 20 min at room temperature (22 • C) and a binding reaction was initiated by the addition of the labelled probes (20 000 c.p.m.). The reaction mixture was then incubated for an additional 30 min at room temperature. The reaction mixture was loaded directly on to a 4 % (37.5:1 acrylamide/bisacrylamide) non-denaturing polyacrylamide gel with 0.25 × Tris/borate/EDTA buffer (1 × buffer = 45 mM Tris/borate and 1 mM EDTA), run at 150 V for 2 h at room temperature and submitted to autoradiography.
qRT-PCR (quantitative real-time PCR) analysis
qRT-PCR was performed as described previously [37] . Briefly, LNCaP cells were grown in Phenol-Red-free RPMI 1640 medium plus 10 % (v/v) charcoal-stripped FBS for 3 days and treated with or without 10 nM R-1881 for 24 h. Total cellular RNA was isolated from cells using TRIzol ® (Qiagen), and cDNA was synthesized via reverse transcription with a ReactionReady TM first-strand cDNA synthesis kit (SuperArray Bioscience). The resulting cDNA product was subjected to PCR amplification with an RT 2 SYBR Green real-time PCR master mix (SuperArray Bioscience) and gene-specific primer sets using a SmartCycler II (Cepheid) under the following conditions: 40 cycles of 30 s at 94
• C, 20 s at 55 • C and 30 s at 72 • C. qRT-PCR primer sets for human PSA (PPH01002A), NKX3-1 (NK3 homeobox 1; PPH02267A), PDEF (prostate-derived Ets factor; PPH02282A), IGFBP5 (PPH00312B), CNTN4 (contactin 4; PPH11523A), PSCA (prostate stem cell antigen; PPH02248A), SGK2 (serum/glucocorticoid-regulated kinase 2; PPH05719A), maspin (PPH00695A), PSMA (prostate-specific membrane antigen; PPH01005A) and β-actin (PPH00037A) were purchased from SuperArray Bioscience. The raw data from the PCRs were processed and quantified using the SmartCycler software program (version 2.0c). Three independent qRT-PCR analyses were performed for each sample, and changes in the expression of AR target genes induced by R-1881 were calculated using the 2 − Ct method [39] .
ChIP (chromatin immunoprecipitation)
ChIP was performed as described previously [40] . Briefly, LNCaP cells were grown in Phenol-Red-free RPMI 1640, supplemented with 10 % (v/v) charcoal/dextran-stripped FBS, for 24 h and transfected with pcDNA3.1 or pcDNA-f:AES. The transfected cells were treated with ethanol (0.1 % final volume) or 10 nM R-1881 for 24 h. Cross-linking was initiated with 11 % (w/v) formaldehyde at room temperature for 10 min and then stopped by addition of glycine to 0.125 M. The cross-linked chromatin was sonicated, using a Branson Sonifier with a 450 microtip (VWR Scientific) at output control 6 and duty cycle 30, to produce DNA fragments of an average size of 1 kb. For immunoprecipitation, 2 μg of antigen-purified anti-AES antibody or purified anti-(rabbit IgG) (Bio-Rad Laboratories) was mixed with 200 μg of the purified cross-linked chromatin and incubated overnight at 4
• C. The immunoprecipitated chromatin was reversed by incubation with 20 μg of RNase A at 37
• C for 30 min, followed by further incubation with 20 μg of proteinase K at 50
• C for 3 h and then at 65
• C overnight. The treated chromatin was used for PCR (30 cycles of denaturation at 95
• C, annealing at 50 • C and extension at 72
• C, each for 0.5 min) with PSA primers (a forward primer of sequence 5 -TCTGCCTTTGTCCGCTAGAT-3 and a reverse primer of sequence 5 -AACCTTCATTCCCCAGGACT-3 ), which amplifies a 212-bp product from − 250 to − 39 upstream of the PSA gene.
RESULTS
The N-terminal region of Groucho proteins inhibits AR-driven transcription
The amino-terminal region of proteins in the Groucho family is highly conserved (Figure 1 ). Two motifs, AH1 and AH2 (amphipathic α-helix 1 and 2), in this region mediate both homo-and hetero-oligomerization between Groucho proteins. Homotetramerization is essential for Groucho-mediated transcriptional repression [29, 41, 42] . As AES inhibits AR-driven gene transcription [27] , we investigated the effect of the other Groucho proteins on AR-dependent transcription using a transient transfection assay. We co-transfected a luciferase reporter plasmid, containing four tandem copies of the ARE derived from the PSA gene upstream of the minimal adenovirus E4 promoter, with expression vectors for human AR and human Groucho proteins ( Figure 2A ) into PC3 cells in the presence or absence of the synthetic androgen R-1881. All proteins were expressed with the FLAG epitope fused at their Nterminal ends, and Western blot analysis with the anti-FLAG monoclonal antibody indicated that they were expressed at comparable levels, with the exception of AES-FHM (FHM is the fused epitopes of FLAG, HA and Myc with sequence MDYKDDDDKYPYDVPDYAEQKLISEEDL) and AES-TLE3c ( Figure 2B ). As shown in Figure 2 (C), AR activated the reporter by approx. 48-fold in the presence of R-1881 and co-expression of human AES strongly inhibited (by 3.2-fold) this AR-dependent transactivation. These results were consistent with those we reported previously [27] . In contrast, co-expressing human TLE2 and TLE3 did not inhibit the reporter activity, indicating that the inhibitory effect on AR-dependent transcription is unique to AES. However, the AES-related N-terminal region of TLE3 (TLE3n, amino acid residues 1-246; Figure 2A ) strongly inhibited AR-dependent transcription (by 4.8-fold). Similarly, the AES-related N-terminal region of TLE2 (TLE2n; amino acid residues 1-234) inhibited AR-dependent transcription (by 1.5-fold). These results suggested that the C-terminal regions of TLE proteins prevent the inhibitory effect of their amino-terminal regions on AR-dependent transcription. Indeed, when we fused the C-terminal regions of TLE proteins with AES at its C-terminus (amino acid residues 235-743 of TLE2 and 247-772 of TLE3; Figure 2A ), it completely abolished the AES-mediated inhibition of AR-driven transcription ( Figure 2C ). Even the short nonspecific peptide FHM when fused with AES at its C-terminal end completely blocked the inhibitory effect of AES on AR-driven transcription. We increased expression of AES-FHM, TLE2 and AES-TLE3c by using double the amount of plasmids in the transfection assay. Western blot analysis indicated that expression of AES-FHM, TLE2 and AES-TLE3c was comparable with to the levels of AES ( Figure 2D , compare lanes 2-4 with lane 1). Under these conditions, AES-FHM, TLE2 and AES-TLE3c still did not inhibit AR-driven transcription ( Figure 2E ).
AES contains an inhibitory domain and two regulatory domains
The AES protein is highly conserved throughout the entire coding region (Figure 1) , and the AH1-and AH2-containing region (amino acid residues 22-98) and the C-terminal region (amino acid residues 190-197) of AES are mostly conserved. On the basis of these structural features, we generated a set of deletions ( Figure 3A) . We fused the AES truncations with the FLAG epitope at the N-terminus and transiently expressed them with or without AR in PC3 cells. Western blot analysis with the monoclonal anti-FLAG antibody revealed that these truncations were expressed at similar levels ( Figure 3B ). Deletion of 21, 50, 98, 129 or 155 amino acid residues from the N-terminus completely abolished the ability of AES to inhibit AR-dependent transcription, indicating that this highly conserved N-terminus is critical for AES function ( Figure 3C ). Deletion of the C-terminus up to amino acid residue 193 did not affect AES-mediated inhibition of the luciferase activity, but further deletion of it, to amino acid residue 189 or 176, resulted in complete loss of the ability of AES to inhibit ARdriven transcription. Thus the conserved C-terminal acidic amino acid residues (Glu 190 -Asp-Asp-Gly 193 ) of AES are important for inhibition of AR-dependent transcription. Surprisingly, further deletion from the C-terminus, to amino acid residues 155 or 129, resulted in much stronger inhibition of the luciferase activity (12.4-fold compared with 2.8-fold with the full-length AES). Additional deletion from the C-terminus completely abolished the ability of AES to inhibit AR transactivation. Therefore the Nterminal 129 amino acid residues are sufficient for the inhibitory effect of AES on AR-driven transcription, which is modulated by further positive (amino acid residues 190-193) and negative (amino acid residues 156-176) regulatory domains.
Homodimerization is essential for AES-mediated repression of AR-driven transcription
Previous studies indicated that the Groucho proteins form tetramers through the AH1 and AH2 domains and that this oligomerization is essential for Groucho-mediated repression of gene expression [29, 41, 42] . Mutating the conserved leucine residues into aspartic acid in the AH1 and AH2 domains can abolish this interaction [29] . We mutated the corresponding leucine residues (Leu 35 and Leu 85 ) and found that mutation of Leu 85 alone, or both Leu 35 and Leu 85 , completely abolished AES-mediated repression of AR-driven transcription ( Figure 3C ). To determine whether AES interacts with itself, we produced [
35 S]methionine-labelled AES using an in vitro transcription and translation system ( Figure 4A, lane 1) . We incubated the labelled AES with FLAG-AES that was immobilized on M2 agarose beads. After incubation, we washed the beads extensively. We then analysed the bound 35 S-labelled AES protein using SDS/PAGE and autoradiography. As a negative control for nonspecific binding, we incubated M2 agarose beads with 35 Slabelled AES at the same time under the same conditions. As shown in Figure 4(A) , the full-length 35 S-labelled AES failed to associate with M2 agarose beads (lane 4), but was retained on M2-AES beads (lane 5). The L35D/L85D mutant AES nonspecifically bound to M2 beads (lane 7), which makes it hard to draw a conclusion on the interactions with the mutant AES proteins. The 35 S-labelled AES-(1-129) interacted with M2-AES-(1-129) beads with much higher affinity than the fulllength AES interacted with itself (lane 9 compared with lane 5), indicating that the C-terminal region from 130 to 197 inhibits the interaction between AES and itself. These results indicate that AES homodimerization is correlated with its inhibitory effect on AR-driven transcription.
The negative regulatory domain of AES inhibits dimerization of AES by interacting with the inhibitory domain
We found that 35 S-labelled AES-(1-129) was retained on the M2-AES-(156-176) beads ( Figure 4A, lanes 10-12) but not on the We immunopurified wild-type, mutant (L36D/L85D) and truncations of AES expressed in bacteria with an M2-agaroseaffinity column and eluted them with anti-FLAG peptides. To determine the native sizes of wild-type, mutated and truncated AES proteins, we analysed the purified recombinant proteins using sucrose-gradient sedimentation. Western blot analysis of fractions with the anti-FLAG monoclonal antibody revealed that full-length wild-type AES and AES-(1-129) were sedimented in fractions 11-13 and 9-11 at the positions corresponding to native sizes of approx. 43 and 25 kDa respectively ( Figure 4B ). These sizes were roughly twice the molecular masses of AES and AES-(1-129), as determined using SDS/PAGE, suggesting that AES and AES-(1-129) form homodimers in the solution. The AES-(L36D/L85D) and AES-(1-176) were sedimented in The strong interaction between AES-(1-129) and itself was correlated with its strong repression of AR-driven transcription ( Figure 3C ). In contrast, the L36D/L85D-mutated AES and AES-(1-176), lacking this intermolecular interaction, did not repress AR-driven transcription. These results suggested that the intermolecular interaction of AES protein is essential for repression of AR-driven transcription and that the regulatory domains in AES modulate its function by regulating this intermolecular interaction.
AES disrupts the AR-N-AR-C interaction
In our mammalian two-hybrid analysis, we observed a 37-fold activation of the pG5-luc reporter when we co-transferred PC3 cells with pACT-AR-N and pBIND-AR-C, indicating a strong AR-N-AR-C interaction ( Figure 5A ). Co-expression of AES, pACT-AR-N and pBIND-AR-C dramatically decreased the reporter activity (by 5.9-fold), indicating that AES inhibited the AR-N-AR-C interaction. The inhibitory domain of AES (amino acids 1-129), which dramatically suppresses ARdriven transcription, inhibited the AR-N-AR-C interaction more strongly than full-length AES (by 14-fold). However, AES-(1-176) and AES-(L36D/L85D), which did not suppress ARdriven transcription, only slightly inhibited the AR-N-AR-C interaction (by 1.6-and 1.9-fold respectively). TLE3 and AESTLE3c had no effect on the AR-N-AR-C interaction. These results indicated that inhibition of the AR-N-AR-C interaction by AES correlated with its inhibitory effect on AR-driven transcription.
Co-expression of pACT-ID and pBIND-MyoD, which we used as positive controls, resulted in activation of the pG5-luc reporter (by 46-fold), which was not inhibited by co-transfection of pcDNA-AES ( Figure 5A ). Expression of pBIND-AR-N, pBIND-AR-C or pBIND-AR only slightly activated the reporter activity. AES inhibited the reporter activity driven by pBIND-AR but not by pBIND-AR-C and pBIND-AR-N, suggesting that the intact N-and C-terminal domains are required for the AES-mediated inhibition of AR transactivation. In has been shown previously that the androgen-induced AR-N-AR-C interaction stabilized the AR protein [19, 20] , and we have also shown previously that expression of AES did not result in AR degradation [27] .
The AR-N (amino acid residues 1-662, containing the Nterminal activation and DNA-binding domains) activated the 4 × ARE-E4-luc reporter in an androgen-independent manner ( Figure 5B ). This activation was not inhibited by AES expression, suggesting that the ligand-binding AR-C is required for AESmediated repression of AR-driven transcription. We examined the AR mutant L26A/L27A, which is known to be defective in AR-N-AR-C interaction [43] , in luciferase assays. As shown in Figure 5 (B), AR-(L26A/L27A) was largely unaffected by the inhibitory effects of AES. The wild-type and mutant AR and AR-N (amino acid residues 1-662) were expressed at the similar levels ( Figure 5B , bottom panel). Thus these results confirmed that the AES-mediated inhibition of AR-dependent transcription was via mediated by disrupting the AR-N-AR-C interaction ( Figure 5C ).
AES inhibits AR-ARE interaction
We used a DNA probe, containing the ARE derived from the PSA promoter, in electrophoretic mobility-shift assays to investigate whether AES affects the binding of AR to DNA. We induced expression of human AES and AES-(1-129) in bacteria (purified proteins are shown in Figure 6A ). The recombinant AR shifted the probe ( Figure 6B, lane 2) , and inclusion of recombinant AES in the reaction dramatically decreased the density of the AR-ARE band ( Figure 6B, lane 4) . The same molar amount (4 fmol) of AES-(1-129) completely abolished the AR-ARE shift ( Figure 6B, lane 3) . The probe where the conserved nucleotides in ARE were mutated did not interact with AR (lanes 5-8). As a negative control, we expressed and purified a Gal4-VP16 fusion protein ( Figure 6A , lanes 11 and 12) and confirmed that both AES and AES-(1-129) did not affect the Gal4-VP16-DNA interaction ( Figure 6B,  lanes 10-12) . CHIP analysis indicated that AES decreased the AR recruitment to the PSA promoter in LNCaP cells ( Figure 6D ). These results suggested that the observed inhibition of AR-driven transcription by AES might have been caused by decreased AR-ARE interaction in the presence of AES.
AES selectively regulates expression of androgen-driven genes
Next, we investigated the promoter and gene specificity of AES. 
DISCUSSION
A previous study demonstrated that AES acts as a co-repressor of AR [27] . In the present study, we identified an inhibitory domain located in the N-terminal region, as well as one positive and one negative regulatory domain located in the C-terminal region of AES. Homodimerization of AES was also shown to be essential for its function in the regulation of androgen-driven gene expression. The negative regulatory domain interacted with the inhibitory domain and inhibited AES homodimerization. However, the positive regulatory domain disrupted this interaction and abolished the inhibitory effect of the negative regulatory domain. We also found that AES suppressed the AR-N-AR-C interaction, inhibited the AR-DNA interaction and selectively regulated the expression of AR target genes in prostate cancer cells.
Using deletion analysis, we found that the N-terminal region of AES (amino acid residues 1-129) suppressed AR-driven transcription more strongly than did the full-length AES. This strong inhibitory effect was correlated with the ability of AES to form homodimers, block AR-N-AR-C interaction and inhibit the AR-DNA interaction. We identified the negative (amino acid residues 156-176) and positive (amino acid residues 190-193) regulatory domains in the AES protein. More intriguingly, we detected a novel intermolecular interaction between the Nterminal inhibitory region and the negative regulatory domain.
Intermolecular interactions play important roles in regulating the functions of various transcription factors [38, [44] [45] [46] . In the present study, this intermolecular interaction strongly inhibited AES homodimerization and AES-mediated inhibition of the AR-N-AR-C interaction, as well as AR-driven gene expression. However, the positive regulatory domain disrupted the intermolecular interaction between the inhibitory domain and the negative regulatory domain, thereby restoring homodimerization and AES-mediated inhibition of AR-N-AR-C interaction. We have therefore revealed the complicated regulatory mechanisms of AES function through intermolecular and intramolecular interactions mediated by different domains within the AES protein. Further studies are needed to investigate the mechanism by which the positive regulatory domain of AES functions.
AR-N-AR-C interaction is an additional regulation point for AR-driven transcription [21, 22] . Indeed, it have been reported that various cofactors differentially influence AR-N-AR-C interaction [21, [23] [24] [25] . We found that AES disrupted the AR-N-AR-C interaction in the mammalian two-hybrid assay. Mutation of the motif involved in the AR-N-AR-C interaction abolished the AESmediated inhibition of AR transactivation. These results clearly linked AES-mediated inhibition of AR-driven transcription with the ability of AES to disrupt the AR-N-AR-C interaction. Some AR co-repressors alter subcellular localization of AR [23] . Expression of AES did not change AR subcellular localization in the present study (results not shown). We, however, observed that AES inhibited the AR-DNA interaction in vitro and in vivo. It is not clear whether AES represses AR action through repression of the AR-N-AR-C interaction, the AR-DNA interaction or both. It was reported that caspase-8 negatively regulated AR transcription, and inhibited both the AR-DNA interaction and AR-N-AR-C interaction [23] . It is not yet clear whether the AR-N-AR-C interaction affects the AR-DNA interaction. If the AR-N-AR-C interaction indeed regulates the AR-DNA interaction, inhibition of AR-driven transcription by AES may be mediated via the down-regulation of the AR-N-AR-C interaction to prevent AR interacting with its target genes.
Similar to AES, the N-terminal regions of Groucho proteins suppressed AR-driven transcription. However, the C-terminal regions of TLE proteins and even a short peptide sequence added to the C-terminal end of AES consistently abolished the inhibition of AR-dependent transcription mediated by AES. These C-terminal protein sequences also abolished the AES-mediated inhibition of AR-N-AR-C interaction.
Although identified by direct AR interactions, investigators have tested most of the AR cofactors solely using transient transfection assays with synthetic ARE-containing luciferase reporters. We observed very little or no promoter selectivity of the AR cofactor AES in the present assays. These results illustrate that short promoters may not be sufficient to discriminate between, and select for, the identities of cofactors which bind to ligand-bound AR. It is also possible that the transiently transfected promoters were not assembled into chromatin appropriately and reduced the AR cofactor selectivity. In contrast with the exogenously transfected promoters, AES showed selectivity for the androgendriven endogenous genes. Specifically, it only affected the androgen-driven expression of five out of the nine genes tested. The promoter context in the endogenous genes was a significant factor in determining the nature and composition of AR cofactor complexes. Thus distinct AR cofactors may be involved in the transcription of a set of genes, and changes in the levels of expression of cofactors may change AR target gene expression profiles in the prostate. Further studies will be needed to determine the promoter elements that determine the gene selectivity of AREs.
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